eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
1/2024
vol. 62
 
Share:
Send email
Share:
Original paper

A current view of mitochondria damage and the diversity of lipopigment inclusions in neuronal ceroid lipofuscinose type 2 from rectal biopsy

Paulina Felczak
1
,
Aleksandra Kuźniar-Pałka
2
,
Agnieszka Ługowska
3
,
Elżbieta Stawicka
2
,
Sylwia Tarka
4
,
Hanna Mierzewska
2

  1. Department of Neuropathology, Institute of Psychiatry and Neurology, Warsaw, Poland
  2. Clinic of Child and Adolescent Neurology, Institute of Mother and Child, Warsaw, Poland
  3. Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland
  4. Department of Forensic Medicine, Warsaw Medical University, Warsaw, Poland
Folia Neuropathol 2024; 62 (1): 21-31
DOI: https://doi.org/10.5114/fn.2023.133795
Online publish date: 2024/03/01
Article file
- A current (1).pdf  [0.76 MB]
Get citation
 
PlumX metrics:
 
1. Anand R, Andreas S, Reichert AS, Kondadi AK. Emerging roles of the MICOS complex in cristae dynamics and biogenesis. Biology 2021; 10: 1-17.
2. Anderson GW, Goebel HH, Simonati A. Human pathology in NCL. Biochim Biophys Acta 2013; 1832: 1807-1826.
3. Audano M, Schneider A, Mitro N. Mitochondria, lysosomes, and dysfunction: Their meaning in neurodegeneration. J Neurochem 2018; 147: 291-309.
4. Baranzehi T, Kordi-Tamandani DM, Najafi M, Khajeh A, Schmidts M. Identification of a TPP1 Q278X mutation in an Iranian patient with neuronal ceroid lipofuscinosis 2: Literature review and mutations update. J Clin Med 2022; 11: 1-12.
5. Ceuterick-de Groote Ch, Martin JJ. Extracerebral biopsy in lysosomal and peroxisomal disorders. Ultrastructural findings. Brain Pathol 1998; 8: 121-132.
6. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006; 125: 1241-1252.
7. Chen ZR, Liu DT, Meng H, Liu L, Bian WJ, Liu XR, Zhu WW, Hea Y, Wanga J, Tanga B, Sua T, Yi YH. Homozygous missense TPP1 mutation associated with mild late infantile neuronal ceroid lipofuscinoses and the genotype-phenotype correlation. Eur J Epilepsy 2019; 69: 180-185.
8. Di Giacopo R, Cianetti L, Caputo V, La Torraca I, Piemonte F, Ciolfi A, Petrucci S, Carta C, Mariotti P, Leuzzi V, Valente EM, D’Amico A, Bentivoglio A, Bertini E, Tartaglia M, Zampino G. Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs. J Neurol Sci 2015; 356: 65-71.
9. Doccini S, Morani F, Nesti C, Pezzini F, Calza G, Soliymani R, Signore G, Rocchiccioli S, Kanninen KM, Huuskonen MT, Baumann MH, Simonati A, Lalowski MM, Santorelli FM. Proteomic and functional analyses in disease models reveal CLN5 protein involvement in mitochondrial dysfunction. Cell Death Discov 2020; 6: 1-14.
10. Gardner E, Bailey M, Schulz A, Aristorena M, Miller N, Mole SE. Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease. Hum Mutat 2019; 40: 1924-1938.
11. Goebel HH, Wisniewski KE. Current state of clinical and morphological features in human NCL. Brain Pathol 2004; 14: 61-69.
12. Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 2003; 62: 1-13.
13. Haltia M. The neuronal ceroid-lipofuscinoses: From past to present. Biochim Biophys Acta 2006; 1762: 850-856.
14. Kim WD, Wilson-Smillie MLDM, Thanabalasingam A, Lefrancois S, Cotman SL, Huber RJ. Autophagy in the neuronal ceroid lipofuscinoses (Batten Disease). Front Cell Dev Biol 2022; 10: 1-28.
15. Kohan R, Cismondi IA, Oller-Ramirez AM, Guelbert N, Tapia Anzolini V, Alonso G, Mole SE, de Kremer RD, de Halac IN. Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses. Curr Pharm Biotechnol 2011; 12: 867-883.
16. Lewandowska E, Lipczyńska-Łojkowska W, Modzelewska J, Wierzba-Bobrowicz T, Mierzewska H, Szpak GM, Pasennik E, Jachińska K. Kufs’ disease: Diagnostic difficulties in the examination of extracerebral biopsies. Folia Neuropathol 2009; 47: 259-267.
17. Lourenco ChM, Pessoa A, Mendes CC, Rivera-Nieto C, Vergara D, Troncoso M, Gardner E, Mallorens F, Tavera L, Lizcano LA, Atanacio N, Guelbert N, Specola N, Mancilla N, de Souza CFM, Mole SE. Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world. J Pediatr Child Health 2021; 57: 519-525.
18. Ługowska A, Purzycka-Olewiecka JK, Płoski R, Truszkowska G, Pronicki M, Felczak P, Śpiewak M, Podlecka-Piętowska A, Sitek M, Bilińska ZT, Leszek P, Bednarska-Makaruk M. Tripeptidyl peptidase 1 (TPP1) deficiency in a 36-year-old patient with cerebellar extrapyramidal syndrome and dilated cardiomyopathy. Life 2022; 12: 1-15.
19. Mole SE, Anderson G, Band HA, Berkovic SF, Cooper JD, kleine Holthaus S-M, McKay TR, Medina DL, Rahim AA, Schulz A, Smith AJ. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 2018; 18: 107-116.
20. Mole SE, Mitchison HM, Munroe PB. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5. Hum Mutat 1999; 14: 199-215.
21. Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Ingrid E. Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis 2021; 16: 1-19.
22. Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 2005; 6: 107-126.
23. Mukherjee AB, Appu AP, Sadhukhan T, Casey S, Mondal A, Zhang Z, Bagh MB. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses. Mol Neurodegener 2019; 14: 1-23.
24. Nijssen PCG, Ceuterick C, van Diggelen OP, Elleder M, Martin JJ, Teepen JLJM, Tyynelä J, Roos RAC. Autosomal dominant adult neuronal ceroid lipofuscinoses: A novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency. Brain Pathol 2003; 13: 574-581.
25. Nita DA, Mole SE, Minassian BA. Neuronal ceroid lipofuscinoses. Epileptic Disord 2016; 18 Suppl. 2: S73-S88.
26. Pasquinelli G, Cenacchi G, Le Piane E, Russo C, Aguglia U. The Problematic issue of Kufs disease diagnosis as performed on rectal biopsies: A case report. Ultrastruct Pathol 2004; 28: 43-48.
27. Pavelka M, Roth J. Fabry disease In: Functional ultrastructure. Atlas of tissue biology and pathology. 3rd ed. Springer Wien, New York 2015; 138-139.
28. Pietrzak A, Badura-Stronka M, Kangas-Kontio T, Felczak P, Kozubski W, Latos-Bielenska A, Wierzba-Bobrowicz T, FlorczakWyspianska J. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome. Folia Neuropathol 2019; 57: 285-294.
29. Plotegher N, Duchen MR. Mitochondrial dysfunction and neurodegeneration in lysosomal storage disorders. Trends Mol Med 2017; 23: 116-134.
30. Rakheja D, Bennett MJ. Neuronal ceroid-lipofuscinoses. Trans Sci Rare Dis 2018; 3: 83-95.
31. Schulz A, Kohlschütter A, Mink J, Simonati A, Williams R. NCL diseases – clinical perspectives. Biochim Biophys Acta 2013; 1832: 1801-1806.
32. Shami GJ, Cheng D, Verhaegh P, Koek G, Wisse E, Braet F. Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease. Sci Rep 2021; 11: 1-14.
33. Simonati A, Williams RE. Neuronal ceroid lipofuscinosis: The multifaceted approach to the clinical issues, an overview. Front Neurol 2022; 13: 1-19.
34. Stephan T, Brüser C, Deckers M, Steyer AM, Balzarotti F, Barbot M, Behr TS, Heim G, Hübner W, Ilgen P, Lange F, Pacheu-Grau D, Pape JK, Stoldt S, Huser T, Hell SW, Möbius W, Rehling P, Riedel D, Jakobs S. MICOS assembly controls mitochondrial inner membrane remodeling and crista junction redistribution to mediate cristae formation. EMBO J 2020; 39: 1-24.
35. van Beersel G, Tihon E, Demine S, Hamer I, Jadot M, Arnould T. Different molecular mechanisms involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient fibroblasts. Biosci Rep 2013; 33: 243-258.
36. Williams RE, Aberg L, Autti T, Goebel HH, Kohlschütter A, Lönnqvist T. Diagnosis of the neuronal ceroid lipofuscinoses: An update. Biochim Biophys Acta 2006; 1762: 865-872.
37. Wortmann SB, Oud MM, Alders M, Coene KLM, van der Crabben SN, Feichtinger RG, Garanto A, Hoischen A, Mirjam Langeveld M, Lefeber D, Mayr JA, Ockeloen CW, Prokisch H, Rodenburg R, Waterham HR, Wevers RA, van de Warrenburg BPC, Willemsen MAAP, Wolf NI, Vissers LELM, van Karnebeek CDM. How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques. J Inherit Metab Dis 2022; 45: 663-681.
38. Yang Z, Wang L, Yang Ch, Pu S, Guo Z, Wu Q, Zhou Z, Zhao H. Mitochondrial membrane remodeling. Front Bioeng Biotechnol 2022; 9: 1-18.
Copyright: © 2024 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Wprowadzenie do neurologopedii Wydanie II zaktualizowane
EVENTS
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.